Chiesi’s proprietary dry powder inhaler device – the NEXTHaler™, was successfully launched in the EU, in 2013.
The simple and intuitive use belies an ingenious and intricate device comprising: a breath-actuated bulk-reservoir dry powder inhaler and an integrated dose counter.
Significant design for manufacture contributed to a successful industrialisation. This was then launched across a number of territories and the subsequent supply of the product at commercial volumes.
We are continuing to work with Chiesi to install manufacturing capacity and to further support the product’s success.